The modulation effect of non-invasive brain stimulation on cognitive function in patients with mild cognitive impairment: a systematic review and meta-analysis of randomized controlled trials - PubMed (original) (raw)

Meta-Analysis

The modulation effect of non-invasive brain stimulation on cognitive function in patients with mild cognitive impairment: a systematic review and meta-analysis of randomized controlled trials

Ying Xu et al. BMC Neurosci. 2019.

Abstract

Background: To prevent and control dementia, many scholars have focused on the transition stage between normal ageing and dementia, mild cognitive impairment (MCI) which is a key interventional target for dementia. Studies have shown that non-invasive brain stimulation (NIBS) is beneficial to improve cognitive function of MCI patients. However, whether NIBS is conducive to the protection of cognitive ability in MCI patients remains unknown due to limited evidence. The aim of the study was to systematically evaluate the modulation effect of NIBS on cognitive function (global cognitive ability and specific domains of cognition) in patients with MCI.

Results: A total of 11 RCTs comprising a total of 367 MCI participants. Meta-analysis showed that NIBS can significantly improve global cognition (n = 271, SMD = 0.94, 95% CI 0.47-1.41, p < 0.0001) and verbal fluency (n = 72, MD = 2.03, 95% CI 0.17-3.88, p = 0.03). However, there was no significant improvement in other domains of cognition.

Conclusions: NIBS has a positive effect on improving global cognitive function and verbal fluency. At the same time, it has a small positive effect on improving executive function. However, these findings should be interpreted carefully due to the limitations of the study.

Keywords: Cognitive function; Meta-analysis; Mild cognitive impairment; Non-invasive brain stimulation.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Flow diagram for searching and selection of the included studies

Fig. 2

Fig. 2

NIBS versus other intervention: global cognitive ability

Fig. 3

Fig. 3

NIBS versus other intervention: memory

Fig. 4

Fig. 4

NIBS versus other intervention: executive ability

Fig. 5

Fig. 5

NIBS versus other intervention: attention

Fig. 6

Fig. 6

NIBS versus other intervention: verbal fluency

Fig. 7

Fig. 7

NIBS versus other intervention: adverse effects

References

    1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang YQ, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112–2117. -PMC -PubMed
    1. Association A. 2012 Alzheimer’s disease facts and figures. Alzheimers Dement. 2012;8(2):131–168. -PubMed
    1. Karakaya T, Fusser F, Schroder J, Pantel J. Pharmacological treatment of mild cognitive impairment as a prodromal syndrome of Alzheimer s disease. Curr Neuropharmacol. 2013;11(1):102–108. -PMC -PubMed
    1. Jia J, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439–447. -PubMed
    1. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008;13(1):45–53. -PubMed

Publication types

MeSH terms

LinkOut - more resources